Clinical Trial Update: A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients [Phase 1]

View source ↗

Summary

Phase 1a/1b trial evaluating PPI-383 in healthy adults and chronic hepatitis C patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PPI-383

Snippet

Sponsor: Presidio Pharmaceuticals, Inc. | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED